{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:08:11Z","timestamp":1790856491904,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023ZYD0066"],"award-info":[{"award-number":["2023ZYD0066"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330030"],"award-info":[{"award-number":["82330030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82121003"],"award-info":[{"award-number":["82121003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lfs.2025.123965","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T21:36:30Z","timestamp":1757540190000},"page":"123965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Reprogramming cysteine metabolism via METTL14-SLC7A11 axis promotes the progression of NAFLD and hepatocellular carcinoma"],"prefix":"10.1016","volume":"380","author":[{"given":"Xing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RuiJi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-7862","authenticated-orcid":false,"given":"Zhenglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-1993","authenticated-orcid":false,"given":"Ziyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.123965_bb0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2025.123965_bb0010","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1002\/jcp.30128","article-title":"HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1\u03b1","volume":"236","author":"Yang","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2025.123965_bb0015","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","article-title":"USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization","volume":"81","author":"Du","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2025.123965_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","article-title":"METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism","volume":"518","author":"Xie","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2025.123965_bb0025","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ymthe.2022.02.021","article-title":"Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"30","author":"Yang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2025.123965_bb0030","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1002\/jcb.26746","article-title":"FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation","volume":"119","author":"Kang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2025.123965_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gendis.2021.01.005","article-title":"Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders","volume":"9","author":"Yang","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.lfs.2025.123965_bb0040","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2025.123965_bb0045","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41419-021-03591-1","article-title":"S-adenosylmethionine upregulates the angiotensin receptor-binding protein ATRAP via the methylation of HuR in NAFLD","volume":"12","author":"Guo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123965_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz2841","article-title":"Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome","volume":"12","author":"Rom","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lfs.2025.123965_bb0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.29465","article-title":"Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance","volume":"67","author":"Gaggini","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2025.123965_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14060325","article-title":"Crosstalk between epigenetics and metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease-induced hepatocellular carcinoma: a new sight","volume":"14","author":"Li","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.lfs.2025.123965_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/HMER.S79100","article-title":"Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease","volume":"7","author":"Kawanaka","year":"2015","journal-title":"Hepatic Med. Evid. Res."},{"key":"10.1016\/j.lfs.2025.123965_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.12.006","article-title":"Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression","volume":"10","author":"Du","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2025.123965_bb0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-3-031-63657-8_18","article-title":"Nonalcoholic fatty liver disease and staging of hepatic fibrosis","volume":"1460","author":"Engin","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2025.123965_bb0080","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI124049","article-title":"Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma","volume":"130","author":"Hu","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2025.123965_bb0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","article-title":"ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis","volume":"79","author":"He","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2025.123965_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04307-1","article-title":"Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11","volume":"12","author":"Dong","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123965_bb0095","article-title":"The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.lfs.2025.123965_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102975","article-title":"Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m(5)c modification of SLC7A11 mRNA","volume":"69","author":"Chen","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2025.123965_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41418-022-01051-7","article-title":"SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma","volume":"30","author":"Chen","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2025.123965_bb0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41556-020-0496-x","article-title":"Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer","volume":"22","author":"Liu","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2025.123965_bb0115","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","article-title":"SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2025.123965_bb0120","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.v25.i31.4300","article-title":"Methionine adenosyltransferases in liver cancer","volume":"25","author":"Murray","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2025.123965_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287657","article-title":"Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes","volume":"18","author":"Suzuki-Kemuriyama","year":"2023","journal-title":"PloS One"},{"key":"10.1016\/j.lfs.2025.123965_bb0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-981-10-8684-7_7","article-title":"Dysregulated Epigenetic Modifications in the Pathogenesis of NAFLD-HCC","volume":"1061","author":"Zhao","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2025.123965_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102963","article-title":"Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO\/SLC7A11 pathway","volume":"68","author":"Jiang","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2025.123965_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-021-02433-6","article-title":"METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification","volume":"22","author":"Xu","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.lfs.2025.123965_bb0145","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s12094-023-03116-6","article-title":"ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells","volume":"25","author":"Luo","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.lfs.2025.123965_bb0150","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00535-023-02008-4","article-title":"N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment","volume":"58","author":"Yang","year":"2023","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.lfs.2025.123965_bb0155","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1038\/s41598-024-55932-7","article-title":"METTL3 and METTL14-mediated N(6)-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2","volume":"14","author":"Wu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2025.123965_bb0160","doi-asserted-by":"crossref","first-page":"10197","DOI":"10.1111\/jcmm.16957","article-title":"Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11","volume":"25","author":"Fan","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2025.123965_bb0165","article-title":"METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy","volume":"4","author":"Pan","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.lfs.2025.123965_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216122","article-title":"METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2025.123965_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112704","article-title":"Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperproliferation","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.lfs.2025.123965_bb0180","first-page":"1","article-title":"Research progress on SLC7A11 in the regulation of cystine\/cysteine metabolism in tumors","volume":"23","author":"Tang","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2025.123965_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103159","article-title":"SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression","volume":"72","author":"Lv","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2025.123965_bb0190","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis","volume":"127","author":"Fang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2025.123965_bb0195","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525006010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525006010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:18:35Z","timestamp":1770916715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525006010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"alternative-id":["S0024320525006010"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123965","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming cysteine metabolism via METTL14-SLC7A11 axis promotes the progression of NAFLD and hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123965","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123965"}}